B. Riley Starts Tandem Diabetes (TNDM) at Buy
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $35.12 +0.43%
Rating Summary:
15 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
15 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
B. Riley initiated coverage on Tandem Diabetes (NASDAQ: TNDM) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Tandem Diabetes click here. For more ratings news on Tandem Diabetes click here.
Shares of Tandem Diabetes closed at $8.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- Piper Sandler Starts Kura Sushi USA Inc. (KRUS) at Neutral, 'Risk Reward as relatively balanced'
- KeyBanc Starts Super Micro Computer (SMCI) at Sector Weight, 'shares currently trading relatively inline with its infrastructure peer group'
Create E-mail Alert Related Categories
New CoverageRelated Entities
B. RileySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
